Suppr超能文献

乳香酸类似物BA145的抗血管生成和细胞毒性作用因自噬抑制剂而增强。

The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors.

作者信息

Pathania Anup S, Wani Zahoor A, Guru Santosh K, Kumar Suresh, Bhushan Shashi, Korkaya Hasan, Seals Darren F, Kumar Ajay, Mondhe Dilip M, Ahmed Zabeer, Chandan Bal K, Malik Fayaz

机构信息

Department of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, Jammu and Kashmir, 180001, India.

Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India.

出版信息

Mol Cancer. 2015 Jan 21;14:6. doi: 10.1186/1476-4598-14-6.

Abstract

BACKGROUND

While angiogenesis inhibitors represent a viable cancer therapy, there is preclinical and clinical data to suggest that many tumors develop resistance to such treatments. Moreover, previous studies have revealed a complex association between autophagy and angiogenesis, and their collective influence on tumorigenesis. Autophagy has been implicated in cytoprotection and tumor promotion, and as such may represent an alternative way of targeting apoptosis-resistant cancer cells. This study explored the anti-cancer agent and boswellic acid analog BA145 as an inducer of autophagy and angiogenesis-mediated cytoprotection of tumor cells.

METHODS

Flow cytometry, western blotting, and confocal microscopy were used to investigate the role of BA145 mediated autophagy. ELISA, microvessel sprouting, capillary structure formation, aortic ring and wound healing assays were performed to determine the relationship between BA145 triggered autophagy and angiogenesis. Flow cytometery, western blotting, and microscopy were employed to examine the mechanism of BA145 induced cell death and apoptosis. Live imaging and tumor volume analysis were carried out to evaluate the effect of BA145 triggered autophagy on mouse tumor xenografts.

RESULTS

BA145 induced autophagy in PC-3 cancer cells and HUVECs significantly impeded its negative regulation on cell proliferation, migration, invasion and tube formation. These effects of BA145 induced autophagy were observed under both normoxic and hypoxic conditions. However, inhibition of autophagy using either pharmacological inhibitors or RNA interference enhanced the BA145 mediated death of these cells. Similar observations were noticed with sunitinib, the anti-angiogenic properties of which were significantly enhanced during combination treatments with autophagy inhibitors. In mouse tumor xenografts, co-treatment with chloroquinone and BA145 led to a considerable reduction in tumor burden and angiogenesis compared to BA145 alone.

CONCLUSION

These studies reveal the essential role of BA145 triggered autophagy in the regulation of angiogenesis and cytoprotection. It also suggests that the combination of the autophagy inhibitors with chemotherapy or anti-angiogenic agents may be an effective therapeutic approach against cancer.

摘要

背景

虽然血管生成抑制剂是一种可行的癌症治疗方法,但临床前和临床数据表明,许多肿瘤会对这种治疗产生耐药性。此外,先前的研究揭示了自噬与血管生成之间的复杂关联,以及它们对肿瘤发生的共同影响。自噬与细胞保护和肿瘤促进有关,因此可能代表了一种靶向抗凋亡癌细胞的替代方法。本研究探索了抗癌药物乳香酸类似物BA145作为自噬诱导剂以及血管生成介导的肿瘤细胞细胞保护作用。

方法

采用流式细胞术、蛋白质印迹法和共聚焦显微镜来研究BA145介导的自噬作用。进行酶联免疫吸附测定、微血管芽生、毛细血管结构形成、主动脉环和伤口愈合试验,以确定BA145引发的自噬与血管生成之间的关系。采用流式细胞术、蛋白质印迹法和显微镜检查来研究BA145诱导细胞死亡和凋亡的机制。进行实时成像和肿瘤体积分析,以评估BA145引发的自噬对小鼠肿瘤异种移植的影响。

结果

BA145诱导PC-3癌细胞自噬,并且人脐静脉内皮细胞(HUVECs)自噬显著阻碍其对细胞增殖、迁移、侵袭和管形成的负调控。在常氧和低氧条件下均观察到BA145诱导自噬的这些作用。然而,使用药理学抑制剂或RNA干扰抑制自噬会增强BA145介导的这些细胞死亡。舒尼替尼也有类似的观察结果,在与自噬抑制剂联合治疗期间,其抗血管生成特性显著增强。在小鼠肿瘤异种移植中,与单独使用BA145相比,氯喹与BA145联合治疗导致肿瘤负荷和血管生成显著降低。

结论

这些研究揭示了BA145引发的自噬在血管生成调节和细胞保护中的重要作用。这也表明自噬抑制剂与化疗或抗血管生成药物联合使用可能是一种有效的癌症治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f21/4509694/fdf44949fa0f/12943_2014_1497_Fig3_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验